A non-comparative randomized phase II study of 2 doses of ATN-224, a copper/zinc superoxide dismutase inhibitor, in patients with biochemically recurrent hormone-naïve prostate cancer
Lin, Jianqing, Zahurak, Marianna, Beer, Tomasz M., Ryan, Charles J., Wilding, George, Mathew, Paul, Morris, Michael, Callahan, Jennifer A., Gordon, Gilad, Reich, Steven D., Carducci, Michael A., AntonVolume:
31
Language:
english
Journal:
Urologic Oncology: Seminars and Original Investigations
DOI:
10.1016/j.urolonc.2011.04.009
Date:
July, 2013
File:
PDF, 462 KB
english, 2013